Carboplatin-Etoposide Chemotherapy (CB-ET) for Patients Diagnosed with Advanced Extra-Pulmonary (EP) Poorly Differentiated (PD) Neuroendocrine Carcinoma (NEC): Findings from a European Neuroendocrine Tumor Society Centre of Excellence

Melissa Frizziero, Angela Lamarca, Zoe Kordatou, Jorge Barriuso, Christina Nuttall, Mairead Mcnamara, Richard Hubner, Wasat Mansoor, Prakash Manoharan, Juan Valle

Research output: Contribution to conferenceAbstractpeer-review

Fingerprint

Dive into the research topics of 'Carboplatin-Etoposide Chemotherapy (CB-ET) for Patients Diagnosed with Advanced Extra-Pulmonary (EP) Poorly Differentiated (PD) Neuroendocrine Carcinoma (NEC): Findings from a European Neuroendocrine Tumor Society Centre of Excellence'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology